We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-1.38%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$97.1B
AUM Growth
+$19.4B
(+25%)
Cap. Flow
+$24.4B
Cap. Flow
% of AUM
25.14%
Top 10 Holdings %
Top 10 Hldgs %
12.02%
Holding
3,234
New
374
Increased
1,828
Reduced
905
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$474M |
| 2 |
Snowflake
SNOW
|
+$418M |
| 3 |
General Motors
GM
|
+$395M |
| 4 |
Roblox
RBLX
|
+$378M |
| 5 |
Adobe
ADBE
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMAR
Smartsheet Inc.
SMAR
|
+$173M |
| 2 |
Progressive
PGR
|
+$158M |
| 3 |
Robinhood
HOOD
|
+$155M |
| 4 |
AbbVie
ABBV
|
+$131M |
| 5 |
Lennar Class A
LEN
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.11% |
| 2 | Financials | 16.12% |
| 3 | Healthcare | 13.87% |
| 4 | Consumer Discretionary | 11.39% |
| 5 | Industrials | 11.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
X4 Pharmaceuticals
XFOR
$424M
| $20.6K | ﹤0.01% |
2,899
+2,004
| +224% | +$27.6K |
|
3127
Navitas Semiconductor
NVTS
$3.55B
| $20.5K | ﹤0.01% |
+10,019
| New | +$28.7K |
|
3128
Plug Power
PLUG
$3.1B
| $19.9K | ﹤0.01% |
+15,232
| New | +$29K |
|
3129
Stereotaxis
STXS
$145M
| $19.8K | ﹤0.01% |
+11,234
| New | +$23.9K |
|
3130
Lightwave Logic
LWLG
$1.16B
| $19.4K | ﹤0.01% |
+18,957
| New | +$29.6K |
|
3131
Nautilus Biotechnolgy
NAUT
$113M
| $18.5K | ﹤0.01% |
+21,442
| New | +$31.9K |
|
3132
Skye Bioscience
SKYE
$19M
| $17.9K | ﹤0.01% |
11,251
-10,402
| -48% | -$28.4K |
|
|
NOTE
3133
DELISTED
FiscalNote
NOTE
| $16.1K | ﹤0.01% |
1,662
-42
| -2% | -$632 |
|
|
EU
3134
enCore Energy
EU
$268M
| $16.1K | ﹤0.01% |
+11,724
| New | +$30.1K |
|
|
ELEV
3135
DELISTED
Elevation Oncology
ELEV
| $14.9K | ﹤0.01% |
+57,530
| New | +$32.8K |
|
3136
Lineage Cell Therapeutics
LCTX
$283M
| $14.4K | ﹤0.01% |
+31,991
| New | +$18.8K |
|
3137
Galectin Therapeutics
GALT
$316M
| $14.1K | ﹤0.01% |
+11,582
| New | +$16.2K |
|
3138
Solid Power
SLDP
$550M
| $14.1K | ﹤0.01% |
+13,420
| New | +$18.4K |
|
3139
Harvard Bioscience
HBIO
$27.6M
| $12.9K | ﹤0.01% |
+2,278
| New | +$29.2K |
|
3140
Pacific Biosciences
PACB
$354M
| $12.9K | ﹤0.01% |
+10,922
| New | +$16.8K |
|
3141
Rekor Systems
REKR
$93.4M
| $12.8K | ﹤0.01% |
+14,380
| New | +$22.7K |
|
3142
LiveOne
LVO
$62.8M
| $11.9K | ﹤0.01% |
+1,700
| New | +$16.7K |
|
3143
Atossa Therapeutics
ATOS
$23.6M
| $10.9K | ﹤0.01% |
+1,083
| New | +$13.1K |
|
|
LNAI
3144
Lunai Bioworks
LNAI
$10.9M
| $10.9K | ﹤0.01% |
250
+119
| +91% | +$7.62K |
|
3145
System1
SST
$17.8M
| $10.7K | ﹤0.01% |
2,802
+975
| +53% | +$5.99K |
|
3146
Veru
VERU
$44.8M
| $8.81K | ﹤0.01% |
+1,798
| New | +$11.1K |
|
|
LYRA
3147
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $7.33K | ﹤0.01% |
1,161
+587
| +102% | +$5.49K |
|
|
SBDS
3148
DELISTED
Solo Brands Inc
SBDS
| $5.53K | ﹤0.01% |
824
-6,684
| -89% | -$205K |
|
3149
Ovid Therapeutics
OVID
$482M
| $4.82K | ﹤0.01% |
15,450
+4,811
| +45% | +$2.96K |
|
3150
Solidion Technology
STI
$67.3M
| $2.44K | ﹤0.01% |
+405
| New | +$7.03K |
|
Similar funds
VGA
AQR Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, AQR Capital Management held 3,234 positions worth $97.1B, up 25% from $77.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
AQR Capital Management deployed $24.4B of net new capital in Q1 2025, opening 374 new positions and adding to 1,828 existing holdings. Its largest new stake was Millrose Properties Inc: 1,839,302 shares worth $48.4M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Progressive, an estimated $158M trimmed.
- AQR Capital Management's largest Q1 2025 buy was Millrose Properties Inc: 1,839,302 shares worth $48.4M.
- AQR Capital Management added most to Arista Networks in Q1 2025, an estimated $474M increase.
- AQR Capital Management's biggest Q1 2025 reduction was Progressive, cutting an estimated $158M.
- AQR Capital Management fully exited Smartsheet Inc. in Q1 2025, selling an estimated $173M.
- AQR Capital Management's ten largest holdings make up 12% of its $97.1B portfolio in Q1 2025.
- AQR Capital Management opened 374 new positions and closed 84 in Q1 2025.
- AQR Capital Management's portfolio value rose 25% quarter-over-quarter to $97.1B.
Based on AQR Capital Management's 13F filing for Q1 2025, filed 15 May 2025.